Clinical Trials Update: July 26, 2006
Multiple Sclerosis Hot Flash Heart Attack (Myocardial Infarction)
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Volunteers 18-55 who have been diagnosed with relapsing-remitting multiple sclerosis and are able to walk without assistance may be eligible for this clinical research study. Participants must a history of taking interferon beta or Copaxone.
The research site is in Sarasota, Fla.
This study will evaluate a non-hormonal medication to see if it can help control hot flashes. You may qualify if you are at least 40 year old, have multiple hot flashes and night sweats each week, had your last period at least six months ago, and are prepared not to use hormone therapy or anti-depressants during this 12-week study.
The research site is in Phoenix, Ariz.
Heart Attack (Myocardial Infarction)
This research trial will evaluate if an experimental drug lowers the risk of heart attack or stroke. Men 50 or older and women 60 or older with no history of heart attack or stroke and low-to-normal LDL (bad) cholesterol may be included. Participants will receive study-related medical evaluations and may receive study drug.
The research site is in Champaign, Ill.
Copyright 2006 Thomson CenterWatch. All rights reserved.